LATEST

Recruitment underway for atopic dermatitis serlopitant trialEarly trial results show a significant reduction of itch with the oral NK-1 antagonist serlopitant
When other treatments fail in atopic dermatitis, dupilumab succeedsDupilumab plus topical corticosteroids safe and effective after failure of cyclosporine in moderate-to-severe atopic dermatitis
Taking a closer look at oral propranolol as first-line treatment in infantile hemangiomaOral propranolol is prescribed for the most serious cases. In this Lancet review, experts highlight some considerations for treatment.
OCPs for teen acne: Seek parental consentHonoring the letter of minor consent laws requires respecting parents' wishes for oral contraceptives prescribed for acne.
EADV touts specific acne quality-of-life toolsEADV experts recommend six quality-of-life measures including the DLQI and Skindex-29 for acne treatment and research.
One word can change a patient’s decision about treatmentWords physicians use and how they say them influences the decisions patients make about treatment for actinic keratosis.
Microneedle pretreatment can shorten PDT treatment time for actinic keratosesExpedited microneedle-assisted photodynamic therapy is a promising option for treatment of actinic keratoses.
Colorscience introduces Clinical Redness CorrectorAll Calmâ„¢ Clinical Redness Corrector is formulated for redness, rosacea and sensitive skin, according to the company.
Redefining skin cancer staging reveals previously hidden casesStaging cutaneous squamous cell skin cancer under AJCC-9 reveals more T3 cases.
Switching from an AIMP to a melanoma diagnosisSignificant residual pigment may indicate elevated melanoma risk in atypical intraepidermal melanocytic proliferation (AIMP) lesions.

Poll

View Results